1. Hodgson, Kirsty, Orozco-Moreno, Margarita, Scott, Emma, Elliott, David J, Munkley, Jennifer. 2023. The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer. In Scientific reports, 13, 17031. doi:10.1038/s41598-023-43019-8. https://pubmed.ncbi.nlm.nih.gov/37813880/
2. Perkey, Eric, Maurice De Sousa, Dave, Carrington, Léolène, Labrecque, Nathalie, Maillard, Ivan. 2020. GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells. In Journal of immunology (Baltimore, Md. : 1950), 204, 1674-1688. doi:10.4049/jimmunol.1901194. https://pubmed.ncbi.nlm.nih.gov/32060138/
3. Chen, Zuxiong, Gulzar, Zulfiqar G, St Hill, Catherine A, Walcheck, Bruce, Brooks, James D. 2014. Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers. In The Prostate, 74, 1059-67. doi:10.1002/pros.22826. https://pubmed.ncbi.nlm.nih.gov/24854630/